Obesity and Chronic Inflammation: Implications for Rheumatoid Arthritis, Spondyloarthritis, and Ulcerative Colitis
Author Information
Author(s): Corrado Ada, Guadagni Ilaria, Picarelli Giovanna, Variola Angela
Primary Institution: University of Foggia, Pfizer Italy, IRCCS Sacro Cuore Don Calabria
Hypothesis
How does obesity influence the progression and management of immune-mediated inflammatory diseases (IMIDs) like rheumatoid arthritis, spondyloarthritis, and ulcerative colitis?
Conclusion
Addressing obesity through lifestyle changes can significantly improve disease outcomes and quality of life for patients with IMIDs.
Supporting Evidence
- Obesity is linked to worse disease activity and treatment response in rheumatoid arthritis patients.
- Patients with obesity and inflammatory bowel disease experience longer hospital stays and more complications.
- Weight loss interventions can lead to decreased production of inflammatory mediators by adipose tissue.
Takeaway
Being overweight can make diseases like arthritis and bowel problems worse, but losing weight can help people feel better and manage their illnesses.
Methodology
This narrative literature review summarizes recent evidence on the interplay between obesity-induced inflammation and immune-mediated inflammatory diseases.
Limitations
The specific molecular mechanisms linking obesity and disease worsening are still unclear.
Participant Demographics
The review focuses on patients with rheumatoid arthritis, spondyloarthritis, and ulcerative colitis, particularly in the Italian context.
Statistical Information
P-Value
p=0.004
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website